M-CSF as a therapeutic target in BRAF V600E melanoma resistant to BRAF inhibitors.
C BarcelóP SisóI de la RosaC Megino-LuqueRaul NavaridasOscar MaiquesI UrdanibiaN EritjaX SoriaM PotronyN Calbet-LlopartSusana Puig SardàX Matías-GuiuRosa María MartíAnna MaciàPublished in: British journal of cancer (2022)
metastatic melanoma patients. These results identify secreted M-CSF as a promising therapeutic target toward BRAFi-resistant melanomas.